Oxaliplatin-induced increase in splenic volume: experiences from multicenter study in Japan

ConclusionThis study can be verified the findings observed in our previous single-center study, oxaliplatin-based adjuvant chemotherapy was associated with an increase in SV. Furthermore, this increase can persist for  >  1 year. The continuous presence of SOS may have a negative impact on prognosis in patients that develop recurrent disease.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research